C5 and fungal infectious disease: Interestingly, a similar differential susceptibility to fungal infection between acute pharmacological inhibition of an immunological pathway and inherited deficiency of the same pathway has also been observed with C5-targeted monoclonal antibody therapy and inherited C5 deficiency (92–94).